New Approach for the Development of a Drug Treatment for Obesity and the Resulting Diseases
The protein Asc-1 regulates whether fat-burning beige or fat-storing white adipocytes are formed, which can have an impact on the development of metabolic diseases. This is shown by a current study of the Helmholtz Zentrum München and the German Center for Diabetes Research (DZD). The results open up new approaches to prevent the development of metabolic diseases. The study has now been published in Nature Communications.
Not all fat is the same: there is white, brown and beige adipose tissue *. While white fat cells serve as energy stores, excess energy is burned in brown and beige fat tissue. Too much white fat is considered unhealthy. If the white adipose tissue increases significantly in adults with obesity, metabolic diseases such as diabetes or metabolic syndrome can develop. The situation is different in children: There, the initial formation of white adipose tissue is a prerequisite for a healthy metabolism. But how does adolescent adipose tissue differs from adult white adipose tissue? To answer this question, researchers have investigated the composition of white adipose tissue of young and adult mice using single cell RNA sequencing**.
Asc-1 promotes the formation of white adipocytes
The researchers found that adolescent adipose tissue differs greatly from adult white fat, especially in terms of the properties and composition of fat precursor cells. The researchers discovered a special subgroup of fat precursor cells in adolescent adipose tissue that contain the protein Asc-1, which is otherwise present in mature adipocytes. These precursor cells differentiate predominantly into white adipocytes, and the formation of "healthy" beige adipocytes is actively suppressed. In further cell biological investigations, the team around first author Lisa Suwandhi were able to show that the loss of Asc-1 function promotes the formation of beige adipocytes.
"These insights into the physiological processes of adipose tissue growth enable us to develop new strategies to prevent the harmful metabolic consequences of obesity," said last author Dr. Siegfried Ussar. The researchers are already pursuing this approach further. They are currently establishing strategies to modulate Asc-1 function in adipose tissue in the living organism and exploring ways to promote healthy adipose tissue expansion. The goal is to help obese patients maintain a healthy metabolism in the future and thus gain time to treat obesity with a holistic approach.
Suwandhi L, Altun I, et al.: Asc-1 regulates white versus beige adipocyte fate in a subcutaneous stromal cell population. Nat Commun. 2021 Mar 11;12(1):1588. doi: 10.1038/s41467-021-21826-9
* Adipose tissue
There are different types of adipose tissue: white, brown and beige. Each of these tissues has specific functions and each plays its own role in the metabolism. In the human body, white adipose tissue represents the largest proportion. It serves primarily as an energy store. Cells of the brown adipose tissue are rich in mitochondria (power plants of the cell). They burn free fatty acids and thus generate heat. Babies in particular have brown adipose tissue. In the adult human body, however, it is only found in a few places. Beige adipocytes develop within the white adipose tissue. However, they are similar to brown adipocytes in their ability to burn excess energy. They are an interesting target for the development of new drug therapies to treat obesity and the resulting diseases such as type 2 diabetes.
** Single-cell RNA sequencing
In simple terms, single-cell RNA sequencing can be used to trace which genes are currently switched on or off in a single cell.
Dr. Siegfried Ussar
Helmholtz Zentrum München
Insitute for Diabetes and Obesity
Ingolstädter Landstraße 1
Phone: +49 89 3187-2047
The Helmholtz Zentrum München, the German Research Center for Environmental Health, pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes, allergies and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München is headquartered in Neuherberg in the north of Munich and has about 2,300 staff members. It is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. www.helmholtz-muenchen.de/en
The German Center for Diabetes Research (DZD) is one of six German Centers for Health Research. It brings together experts in the field of diabetes research and combines basic research, epidemiology and clinical application. By adopting a novel, integrative approach to research, the DZD aims to make a substantial contribution to the successful, personalized prevention, diagnosis and treatment of diabetes mellitus. The members of the association are Helmholtz Zentrum München – German Research Center for Environmental Health, the German Diabetes Center (DDZ) in Düsseldorf, the German Institute of Human Nutrition (DIfE) in Potsdam-Rehbruecke, the Institute of Diabetes Research and Metabolic Diseases of Helmholtz Zentrum München at the University of Tübingen, and the Paul Langerhans Institute Dresden of Helmholtz Zentrum München at the University Medical Center Carl Gustav Carus of TU Dresden, associated partners at the universities in Heidelberg, Cologne, Leipzig, Lübeck and Munich, as well as other project partners. www.dzd-ev.de/en